Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies
Jennifer L. McGuire(Children's Hospital of Philadelphia), Juliane Gust(University of Washington), Yimei Li(Children's Hospital of Philadelphia), Aimee C. Talleur(St. Jude Children's Research Hospital), Rebecca Epperly(St. Jude Children's Research Hospital), Nirali N. Shah(National Institutes of Health), Emily M. Hsieh(Children's Hospital of Los Angeles), Bonnie Yates(National Institutes of Health), Swati Naik(St. Jude Children's Research Hospital), Agne Taraseviciute(Seattle Children's Hospital), Jason N. Wright(Seattle Children's Hospital), Aashim Bhatia(Children's Hospital of Philadelphia), Haneen Shalabi(Center for Cancer Research), Caroline Diorio(Children's Hospital of Philadelphia), Carly Westermann(Quinnipiac University), Rebecca Gardner(Seattle Children's Hospital), Murat Alp Öztek(University of Washington), Regina M. Myers(Children's Hospital of Philadelphia), Colleen Annesley(Unknown), Naomi Torres Carapia(Children's Hospital of Los Angeles), Ritu Shah(The University of Texas MD Anderson Cancer Center), Soniya Pinto(St. Jude Children's Research Hospital), Esin Nur Erdogan(Norcliffe Foundation), Arastoo Vossough(Children's Hospital of Philadelphia)
Cited by 8
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Evidence for 28 genetic disorders discovered by combining healthcare and research data
|Nature|2020|672
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422
CD19 CAR T cell product and disease attributes predict leukemia remission durability
|Journal of Clinical Investigation|2019|355